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MicroRNA-31 Promotes Skin Wound Healing by
Enhancing Keratinocyte Proliferation and Migration
Dongqing Li1, Xi Li1, Aoxue Wang1,2, Florian Meisgen1, Andor Pivarcsi1, Enikö Sonkoly1, Mona Ståhle1 and
Ning Xu Landén1
Wound healing is a basic biological process restoring the integrity of the skin. The role of microRNAs during this
process remains largely unexplored. By using an in vivo human skin wound healing model, we show here that
the expression of miR-31 is gradually upregulated in wound edge keratinocytes in the inﬂammatory (1 day after
injury) through the proliferative phase (7 days after injury) in comparison with intact skin. In human primary
keratinocytes, overexpression of miR-31 promoted cell proliferation and migration, whereas inhibition of miR-31
had the opposite effects. Moreover, we identiﬁed epithelial membrane protein 1 (EMP-1) as a direct target of
miR-31 in keratinocytes. The expression of EMP-1 in the skin was negatively correlated with the level of miR-31
during wound healing. Silencing of EMP-1 mimicked the effects of overexpression of miR-31 on keratinocyte
proliferation and migration, indicating that EMP-1 is a critical target mediating the functions of miR-31 in
keratinocytes. Finally, we demonstrated that transforming growth factor-β2, which is highly expressed in skin
wounds, upregulated miR-31 expression in keratinocytes. Collectively, we identify miR-31 as a key regulator for
promoting keratinocyte proliferation and migration during wound healing.
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INTRODUCTION
Cutaneous wound healing is a highly orchestrated biological
process, which is essential to restore the integrity of the skin
barrier. The classical model of wound healing consists of four
sequential, yet overlapping phases: hemostasis (up to several
hours after injury), inﬂammation (1–3 days after injury),
proliferation (4–21 days after injury), and tissue remodeling
(21 days-1 year after injury; Gosain and DiPietro, 2004). Re-
epithelialization is a crucial process, which entails resurfacing
of the wound with new epithelium and requires proper
migration and proliferation of keratinocytes at the periphery of
the wound (Santoro and Gaudino, 2005). Defects of re-
epithelialization are associated with chronic non-healing
wounds, which affect about 1–2% of the population in
developed countries and present a major and rising health
and economic burden to society (Sen et al., 2009). The
complex nature of wound healing process makes it
challenging to develop effective therapies. Current treat-
ments for chronic ulcers focus mainly on optimization of
controllable healing factors—e.g., nutritional support, infec-
tion clearance, and mechanical support. Few targeted approa-
ches have been developed—e.g., topical application of
growth factor, such as platelet-derived growth factor
(Sun et al., 2014a).
MicroRNAs (miRNAs) are ~22nt noncoding RNAs, which
are being recognized as important gene regulators during
the last decade (He and Hannon, 2004). In humans, miRNAs
are proposed to regulate ~60% of all protein-coding
genes (Friedman et al., 2009) and are thus involved in
most biological processes investigated—e.g., development,
organogenesis, apoptosis, and cell proliferation (Iorio and
Croce, 2012; Ha and Kim, 2014). Deregulation of miRNA
expression has been implicated in the pathogenesis of many
diseases, such as cancer, infection, and chronic inﬂammatory
diseases (Bertero et al., 2011; Iorio and Croce, 2012; O'Connell
et al., 2012). Increasing pre-clinical and clinical studies have
demonstrated that modulation of miRNA expression by
administration of speciﬁc miRNA mimics or inhibitors may
be beneﬁcial for treating diseases (Hydbring and Badalian-
Very, 2013; Nana-Sinkam and Croce, 2013). Thus, miRNAs
represent potentially important therapeutic targets.
Although in recent years increasing studies have revealed
the important roles of miRNAs in skin biology and diseases
(Schneider, 2012), the understanding of their role in the
wound healing process is still in its infancy. MiR-31 has
been implicated as an important regulator of keratinocyte
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biology—e.g., differentiation and hair growth (Mardaryev
et al., 2010; Peng et al., 2012). Moreover, the upregulation of
miR-31 has been reported in several skin diseases character-
ized by excessive keratinocyte proliferation—e.g., psoriasis, a
chronic inﬂammatory skin disease sharing many features with
wound healing (Xu et al., 2012; Morhenn et al., 2013) and
cutaneous squamous cell carcinoma (Bruegger et al., 2013;
Wang et al., 2014). We hypothesize that miR-31 may also
play a role during skin wound healing—e.g., by regulating
keratinocyte proliferation. Therefore, here we focused on
miR-31 and studied its expression and function in human
skin wound healing. We show that miR-31 is gradually
upregulated in wound edge keratinocytes in the inﬂammatory
phase and proliferative phase of wound healing and that it
promotes cell proliferation and migration by suppressing its
direct target gene, epithelial membrane protein 1 (EMP-1). We
identify transforming growth factor-β2 (TGF-β2), which is
highly expressed in the wound bed, as an inducer of miR-31
expression. Taken together, our study suggests that miR-31
may be a potential therapeutic target for promoting skin
wound healing.
RESULTS
MiR-31 is upregulated in epidermal keratinocytes during human
skin wound healing
To study the expression of miRNAs during human skin wound
healing, we created surgical wounds in the abdominal skin of
17 healthy volunteers (Supplementary Table S1 online).
Wound edge tissues were collected 1 day (inﬂammatory
phase) and 7 days (proliferative phase) after injury
(Supplementary Figure S1 online). The histological changes
of the human skin wound during healing process are shown in
Supplementary Figure S2 online.
Herein, we focused on miR-31 and characterized its
expression pattern throughout the entire healing process.
Real-time quantitative reverse transcription–PCR (qRT-PCR)
analysis revealed that the basal level of miR-31 in human skin
is low but rapidly increasing 1.9-fold 1 day after injury
(P= 0.008; Figure 1a). In the subsequent proliferative phase
(7 days post wounding), the expression of miR-31 was
continuously upregulated 7.7-fold (P= 0.003) compared with
the unwounded skin. Moreover, in the same wound biopsies,
we analyzed the expression of primary miR-31 transcripts (pri-
miR-31), from which mature miR-31 is processed (Figure 1b).
Pri-miR-31 was increased in the proliferative phase (5.6-fold,
P=0.007) compared with the unwounded skin (Figure 1b),
positively correlating with the level of mature miR-31
(R= 0.69, P=0.0017; Figure 1c).
To identify the cell type(s) responsible for the dynamic
changes of miR-31 expression during wound healing, we
performed in situ hybridization (Figure 1d). In line with the
qRT-PCR results, the expression of miR-31was low in
unwounded skin (day 0), and its signal was mainly localized
in the basal layer of epidermal keratinocytes. The level of
miR-31 was markedly upregulated in the proliferative phase
(day 7), spreading to the suprabasal cell layers at the wound
edge. Minor amounts of miR-31 may also be present in
dermal ﬁbroblasts and inﬁltrating immune cells. To clarify the
expression pattern in detail, we separated the epidermis and
dermis of the wound biopsies from healthy donors (n= 5) by
using laser capture microdissection and analyzed the expres-
sion of miR-31 by qRT-PCR (Figure 1e and Supplementary
Figure S3 online). Our results show that miR-31 expression is
mainly upregulated in the epidermis compared with the
dermis during wound healing, which is in line with the PCR
data of miR-31 expression in whole skin biopsies (Figure 1a)
and in situ hybridization (Figure 1d). Taken together, our
results demonstrate that epidermal keratinocytes are the
primary cells of interest for functional studies of miR-31
during skin wound healing.
MiR-31 promotes keratinocyte proliferation
Given that miR-31 is highly upregulated in keratinocytes at
the wound edge in the proliferative phase, we further studied
the role of miR-31 in keratinocyte proliferation. To this end,
we overexpressed or inhibited miR-31 in human primary
keratinocytes by transient transfection of miR-31 speciﬁc
precursor RNA (Pre-miR-31) or inhibitor (Anti-miR-31),
respectively. The efﬁciency of overexpression or inhibition
of miR-31 was conﬁrmed by qRT-PCR (Supplementary Figure
S4 online).
We performed the CyQUANT cell proliferation assay for
the keratinocytes with modiﬁed miR-31 expression, which
showed that overexpression of miR-31 increased, whereas
inhibition of miR-31 decreased the number of viable cells in
culture (Figure 2a and Supplementary Figure S5 online). We
also observed the increased expression of the proliferation
marker Ki-67 in keratinocytes with overexpressed miR-31,
whereas Ki-67 was reduced upon miR-31 inhibition
(Figure 2b). These results were further conﬁrmed by the 5-
ethynyl-2′-deoxyuridine (EdU) incorporation assay. Inhibition
of miR-31 decreased cell proliferation, as evidenced by the
reduced percentage of EdU-positive cells and the cells within
S-phase (Figure 2c). Furthermore, using colony formation
assays, we found that miR-31 enhanced the long-term growth
of keratinocytes (Figures 2d and e). Collectively, we
demonstrate that miR-31 is a positive regulator of keratinocyte
growth, reﬂected by both immediate increase of cell cycle
progression and long-term promotion of self-renewal.
MiR-31 enhances keratinocyte motility
Migration of keratinocytes is one of the essential biological
processes for epidermal repair (Haase et al., 2003); therefore,
we aimed to determine the role of miR-31 in keratinocyte
migration. To that end, we performed scratch assays that
showed that overexpression of miR-31 signiﬁcantly acceler-
ated the healing rate of keratinocytes 24 hours after scratching
(1.84-fold, P= 0.0001; Figure 3a), whereas inhibition of
endogenous miR-31reduced the rate of keratinocyte migra-
tion (0.19-fold, P=0.004 at 7 hours; 0.33-fold, P= 0.00001 at
24 hours; Figure 3b and Supplementary Figure S5 online). In
line with this, by using the haptotactic transwell migration
assay, we found that overexpression of miR-31strikingly
increased (3.6-fold, P= 0.04) the migration capacity of
keratinocytes (Figure 3c). Vice versa, inhibition of miR-31
resulted in a signiﬁcant decrease (0.33-fold, P= 0.003) in cell
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migration (Figure 3d). Together, our data identify miR-31 as a
positive regulator of keratinocyte motility.
EMP-1 is targeted by miR-31 in keratinocytes
MiRNAs exert biological functions through regulating their
target genes. Thus, we aimed to identify the target gene
mediating the biological effects of miR-31 in keratinocytes. To
predict the potential targets for miR-31, we performed an
integrated analysis using three independent algorithms:
TargetScan (Lewis et al., 2005), miRanda (John et al., 2004),
and miRWalk (Dweep et al., 2011). Hundred putative miR-31
targets were commonly predicted by all three algorithms
(Figure 4a and Supplementary Table S2 online). To identify
targets that are regulated by miR-31 in keratinocytes, we
revisited the data from our previous study (Xu et al., 2012), in
which transcriptome analysis was performed on keratinocytes
after inhibition of miR-31 (GSE41905). Among the 100 targets
commonly predicted by all three algorithms, four genes were
signiﬁcantly upregulated (fold change ⩾ 1.2, Po0.05) upon
miR-31 inhibition (Supplementary Table S2 online). In this
study, we focused on one of them, EMP-1, as it had been
previously identiﬁed as a direct target of miR-31 in
esophageal squamous cell carcinoma (Zhang et al., 2011),
containing a conserved binding site for miR-31 in its 3′-
untranslated region (3′-UTR) of mRNA (Figure 4b; Lewis et al.,
2005). Notably, EMP-1 has been shown to regulate cancer
cell proliferation and migration in several previous studies
(Zhang et al., 2011; Sun et al., 2013; Sun et al., 2014b; Sun
et al., 2014c; Sun et al., 2014d).
First, we examined whether EMP-1 was directly targeted
by miR-31 in human primary keratinocytes. We performed
3′-UTR luciferase reporter assays with reporter gene con-
structs containing the full-length 3′-UTR of EMP-1 mRNA in
human primary keratinocytes (Figures 4b and c). The wild-
type EMP-1 3′-UTR luciferase activity was decreased (0.78-
fold, P= 0.009) by miR-31 overexpression, whereas mutation
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Figure 1. MiR-31 is upregulated during skin wound healing. The expressions of miR-31 (a) and of primary miR-31 transcript (pri-miR-31; b) were analyzed
in wound biopsies from healthy donors (n= 7) before or 1 and 7 days after injury using real-time quantitative reverse transcription–PCR (qRT-PCR). (c) Correlation
of miR-31 with pri-miR-31 expression in human wound biopsies 1 and 7 days after injury, Spearman-correlation on log-transformed values. (d) In situ
hybridization was performed on wound biopsies from healthy donors (n= 7) using miR-31-speciﬁc probe or scrambled probe. Blue-green color indicates
miR-31 expression. Black arrow demarcates wound edges on day 1, whereas red one points at newly formed epidermis on day 7 post wounding.
Scale bar = 100 μm. (e) The Epidermis and dermis in wound biopsies from healthy donors (n=5) before or 1 and 7 days after injury were separated by
laser capture microdissection. The expression of miR-31 were analyzed using qRT-PCR. MiR-31 and pri-miR-31 PCR data are expressed in relative units (RU)
compared with RNU48 RNA and 18S ribosomal RNA, respectively. Results for individual donors and mean± SD are shown. *Po0.05 and **Po0.01;
the Mann–Whitney U-test.
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of the predicted target site completely abolished the effect of
miR-31 on reporter gene expression. These data demonstrate
that miR-31 directly regulates EMP-1 expression by binding to
the predicted target site in its 3′-UTR. In line with this, we
found that overexpression of miR-31 in keratinocytes sig-
niﬁcantly decreased EMP-1 expression, whereas inhibition of
miR-31 led to an increased expression of EMP-1, both at
mRNA (Figure 4d and Supplementary Figure S6 online) and
protein levels (Figure 4e). Next, we analyzed the expression of
EMP-1 in human in vivo wounds collected at different stages
of the healing process. EMP-1 expression level was rapidly
increased 3.5-fold (P= 0.001) 1 day after injury in comparison
with the unwounded skin as measured by qRT-PCR; however,
its expression returned to basal levels 7 days after injury
(Figure 4f). Notably, there was a signiﬁcant negative correla-
tion (R=−0.76, P= 0.0071) between the expression of EMP-1
and mature miR-31 in the human wound biopsies 1 and
7 days after injury (Figure 4g). Using immunoﬂuorescence
staining, we observed that EMP-1 protein was expressed by all
layers of epidermal keratinocytes in unwounded human skin,
and its signal was stronger in the granular layers (Figure 4h). In
line with the qRT-PCR data, the expression of EMP-1 was
highly upregulated 1 day after injury and diminished 7 days
post wounding (Figure 4h). This reciprocal expression pattern
of miR-31 and EMP-1 both in vitro and in vivo supports that
miR-31 targets EMP-1 in keratinocytes and the increased
expression of miR-31 may be critical in reducing the EMP-1
level during skin wound healing.
Silencing of EMP-1 promotes keratinocyte proliferation and
migration
The function of EMP-1 in keratinocytes is largely unexplored.
To determine whether the effects of miR-31 on keratinocyte
proliferation and migration could be mediated through
EMP-1, we silenced the expression of EMP-1 in keratinocytes
by transfection of two different EMP-1-speciﬁc small interfer-
ing RNAs (siRNAs)—i.e., EMP-1 si-1 and EMP-1 si-2. The
silencing efﬁciency of both siRNAs was conﬁrmed by qRT-
PCR (Figure 5a) and western analysis (Figure 5b). Reduced
expression of EMP-1 by siRNAs led to a signiﬁcant increase in
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Figure 2. MiR-31 promotes keratinocyte proliferation. (a) Keratinocytes were transfected with 20 nM pre-miR-31/anti-miR-31 for 48 hours. The number of viable
cells in culture was quantiﬁed by the CyQUANT cell proliferation assay. (b) The expression of proliferation marker Ki-67 was analyzed in the transfected
keratinocytes using real-time quantitative reverse transcription–PCR. Data are expressed in relative units (RU) compared with 18 s ribosomal RNA with
mean± SD (c) Keratinocytes were transfected with 20 nM anti-miR-31 or anti-miR-control (Ctr) for 48 hours. Cell proliferation and cell cycle progression
were measured by 5-ethynyl-2′-deoxyuridine (EdU) labeling and subsequent cell cycle analysis by ﬂow cytometry. Percentage of cells in the G1, S, and
G2/M phase of cell cycle and percentage of EdU+ cells are shown. (d) Colonies formed by the transfected keratinocytes were stained with crystal violet
8 days after transfection. (e) Crystal violet was dissolved and absorbance value was measured at 540 nm. Data of one representative experiment out of
four independent experiments are shown with mean± SD *Po0.05 and ***Po0.001; Student’s t-test.
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the level of proliferation marker Ki-67 (Figure 5c) and the
colony formation capacity of keratinocytes (Figures 5d and e),
indicating that EMP-1 inhibits keratinocyte growth. Moreover,
the results of scratch assay showed that silencing of EMP-1
increased the migratory capacity of keratinocytes (Figures 5f
and g). Taken together, silencing of EMP-1 promotes
proliferation and migration of keratinocytes, which pheno-
copies the effects of miR-31 overexpression. These data
indicate that EMP-1 is an important target mediating the
biological functions of miR-31 in keratinocytes.
MiR-31 expression is induced by TGF-β2 in keratinocytes
It has been shown that both TGF-β1 and TGF-β2 are crucial
cytokines in regulating keratinocyte migration and prolifera-
tion during re-epithelialization, and their levels are upregu-
lated in skin wounds (Ramirez et al., 2014). We have
previously identiﬁed TGF-β1 as an inducer of miR-31
expression in keratinocytes (Xu et al., 2012). Here we
evaluated the effect of TGF-β2 on miR-31 expression,
showing that it signiﬁcantly increases the expression of both
miR-31 (1.4-fold, P= 0.037; Figure 6a and Supplementary
Figure S7 online) and its primary precursor pri-miR-31 (4.4-
fold, P= 0.0001; Figure 6b) in keratinocytes. Moreover, when
we treated keratinocytes with the TGF-β receptor inhibitor
SB431542, the inducible effect of TGF-β2 on miR-31
expression was abolished (Figures 6c and d). Accordingly,
we found that silencing of TGF-β2 expression in keratinocytes
with siRNAs decreased the expression of both miR-31 and pri-
miR-31 (Figures 6e and f), indicating that the TGF-β2-
mediated-regulation of miR-31 expression also involves
autocrine-signaling pathways. In line with this, we show that
TGF-β2 signiﬁcantly inhibited EMP-1 expression in keratino-
cytes, which may at least partially be mediated by the
increased expression of miR-31 (Figure 6g). Interestingly, we
found that silencing of EMP-1 expression decreased miR-31
expression in keratinocytes (Supplementary Figure S8 online),
suggesting that the high level of EMP-1 during the inﬂamma-
tory phase may be another trigger factor of miR-31 expression
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in addition to TGF-β. Collectively, our results suggest that
the increased levels of TGF-β in wounds contribute to the
upregulation of miR-31 in the keratinocytes.
DISCUSSION
In this study, we characterize the miR-31 expression during
human in vivo wound healing process. We show that miR-31
is mainly expressed in epidermal keratinocytes, in accor-
dance with our previous observation (Xu et al., 2012). The
expression of miR-31 is low in the intact skin; however, upon
wounding, its level gradually increases from the inﬂammatory
phase through the proliferative phase. In comparison with the
expression pattern of its primary transcript, pri-miR-31, which
is only upregulated in the proliferative phase, we conclude
that miR-31 may be regulated during wound healing at
different levels: the raised amounts of mature miR-31 in the
inﬂammatory phase is most likely due to the more efﬁcient
processing of existing pri-miR-31, whereas in the subsequent
proliferative phase the further upregulation of miR-31 expres-
sion also requires increased transcription of the miR-31 gene.
The next question was whether this characteristic expres-
sion pattern of miR-31 correlates with its biological function
during skin wound healing. By using multiple functional
assays in human primary keratinocytes with modiﬁed miR-31
expression, we demonstrate that miR-31 promotes both the
proliferation and migration of keratinocytes, which are crucial
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cellular events during the proliferative phase of wound
healing and essential for re-epithelialization. Migration of
keratinocytes at the wound edge is stimulated by lack of
contact inhibition and many factors active during wound
healing—e.g., epidermal growth factor, keratinocyte growth
factor, and TGF-βs (Reinke and Sorg, 2012). Our study adds
miR-31 to a growing number of miRNAs implicated in the
regulation of keratinocyte migration—e.g., miR-21 (Ahmed
et al., 2011; Yang et al., 2011), miR-203 (Viticchie et al.,
2012), miR-483-3p (Bertero et al., 2011), and miR-24 (Amelio
et al., 2012). Keratinocytes in the wound margins with mitotic
ability, which may include epidermal stem cells, transiently
amplifying cells and early differentiated cells (Li et al., 2004),
start to proliferate toward the end of inﬂammatory phase and
provide more cells for migration to close the wound (Morasso
and Tomic-Canic, 2005). Thus, the high expression of miR-31
in keratinocytes in the proliferative phase may contribute to
the re-epithelialization process.
In addition to its effects on keratinocyte growth and motility
during wound healing, miR-31 is involved in several other
physical processes of the skin. During the hair cycle, miR-31
is upregulated in the anagen phase and inhibition of miR-31
accelerates anagen development (Mardaryev et al., 2010).
Also, miR-31 regulates epidermal keratinocyte differentiation
by enhancing Notch signaling (Peng et al., 2012). Moreover,
the upregulation of miR-31 has been reported in several skin
diseases, such as psoriasis, which shares many features with
wound healing (Morhenn et al., 2013). MiR-31 is over-
expressed in epidermal keratinocytes of psoriasis patients,
promoting cytokine and chemokine production by keratino-
cytes, and contributes to skin inﬂammation (Xu et al., 2012).
Recently, the increased expression of miR-31 was found in
cutaneous squamous cell carcinoma, and it functions as an
oncomiR by increasing the motility and colony-forming ability
of cancer cells (Bruegger et al., 2013; Wang et al., 2014).
Taken together, miR-31 is a multifunctional miRNA playing
important roles in both physiological and pathological
conditions of epidermal keratinocytes.
Identiﬁcation of the direct target of miR-31 is critical
for understanding its mechanism of action in keratinocytes.
In this study, we demonstrate that miR-31 targets EMP-1 in
keratinocytes, in accordance with a previous report in
esophageal squamous cell carcinoma (Zhang et al., 2011).
In line with this, we observed a reciprocal expression pattern
between miR-31 and EMP-1 in the epidermal keratinocytes at
human wound edge during healing process, indicating that
miR-31 may control the level of EMP-1 in vivo. However, in
the inﬂammatory phase, the expression of miR-31 is only
increased slightly, which cannot explain the surge in EMP-1
expression at this time point. Presumably EMP-1 expression
may be triggered by other unknown mechanisms. Previously,
EMP-1 has mainly been described as a tumor suppressor—
e.g., it inhibits tumor cell growth and motility in gastric
carcinoma (Sun et al., 2014b), colorectal carcinoma
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Figure 5. Silencing of epithelial membrane protein 1 (EMP-1) expression increases keratinocyte proliferation and migration. Keratinocytes were transfected
with 30 nM EMP-1 small-interfering RNAs (EMP-1 si-1 or EMP-1 si-2) or siRNA-negative control (Ctr si) for 48 hours. The silencing efﬁciency was analyzed
by measuring EMP-1 mRNA with qRT-PCR (a) and western blotting (b). (c) The expression of proliferation marker Ki-67 was analyzed in these transfected
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(d) and quantiﬁed (e). Scratch assays were performed to assess the migration rate of keratinocytes transfected with EMP-1 siRNAs. Photographs were
taken at indicated time points after scratch injury (f), and the healing rates were quantiﬁed (g). Data of one representative experiment out of four independent
experiments are shown with mean± SD *Po0.05, **Po0.01, and ***Po0.001; Student’s t-test.qRT-PCR, real-time quantitative reverse transcription–PCR;
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(Sun et al., 2014c), breast carcinoma (Sun et al., 2014d),
nasopharyngeal cancer (Sun et al., 2013), and esophageal
squamous cell carcinoma (Zhang et al., 2011). Here we found
that EMP-1 also suppressed the growth and migration of
normal epidermal keratinocytes. During the transition from
the inﬂammatory to the proliferative phase, the expression of
miR-31 is highly upregulated, which results in the reduced
expression of its target, EMP1, and thus assuring proper re-
epithelialization during skin wound healing. Therefore, in this
study, we identiﬁed a mechanism mediating the biological
functions of miR-31 in skin wound repair—i.e., miR-31
unblocks the EMP-1-dependent repression of keratinocyte
proliferation and migration.
Another important question is why miR-31 is upregulated in
the wound edge keratinocytes during the healing process.
Previously, we performed a systematic screen using different
cytokines, growth factors, and factors modulating cell
differentiation and identiﬁed TGF-β1 as a potent regulator of
miR-31 expression in keratinocytes (Xu et al., 2012). Here we
expanded the previous ﬁndings and show that TGF-β2 can
also induce the expression of both mature miR-31 and
primary transcripts of miR-31. Binding of TGF-βs to their
receptors leads to the activation of downstream Smad
proteins, which induce the expression of TGF-β target genes
(Ramirez et al., 2014), e.g., miR-31, as shown in our study. It
has been known that, upon injury, both TGF-β1 and TGF-β2
are highly upregulated in the skin wounds, promoting
keratinocyte migration and re-epithelialization (Ramirez
et al., 2014), and these effects may be at least partially
mediated through induction of miR-31 expression. Moreover,
we found that silencing of EMP-1 expression decreased the
level of miR-31 in keratinocytes, suggesting that the high level
of EMP-1 during the inﬂammatory phase may be another
trigger factor of miR-31 expression in addition to TGF-β. The
EMP-1-induced-miR-31-expression may function as a nega-
tive feedback to ‘turn-off’ the adverse effects of EMP-1 during
the later phase of wound healing.
Taken together, our studies propose a model, in which
miR-31 is induced by TGF-β1 and TGF-β2 in wound edge
keratinocytes. Overexpression of miR-31 increases the pro-
liferation and migration of keratinocytes at least partially by
targeting EMP-1 (Figure 6h). These ﬁndings suggest that
increasing the level of miR-31 in skin wounds may be a
strategy to improve healing. Thus, miR-31 may be a promising
candidate for further investigations of miRNA-based
therapeutics.
MATERIALS AND METHODS
RNA extraction, qRT-PCR, in situ hybridization, cell culture methods,
cell growth, and motility analysis are described in the Supplementary
Materials and Methods online.
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Human wound biopsies
Healthy volunteers (n= 17) were enrolled at Karolinska University
Hospital Dermatology Clinic, Stockholm, Sweden (Supplementary
Table S1 online). Full-thickness skin wounds were made with a 3-mm
biopsy punch in the abdominal region of the healthy volunteers. On
day 1 and day 7 after injury, the wound edge area was excised with
a 6-mm biopsy punch and snap frozen (Supplementary Figure S1
online). The clinical material was obtained after written informed
consent, and the study was approved by the Stockholm Regional
Ethics Committee and conducted according to the Declaration of
Helsinki Principles.
Laser capture microdissection
Frozen wound biopsies were embedded in Tissue-Tek (Thermo
Scientiﬁc, Waltham, MA), and 8-μm tissue sections were cut and
stained with hematoxylin. Laser capture microdissection was
performed with Leica LMD7000 (Leica, Bernried, Germany). RNA
from microdissected tissue was puriﬁed using the miRNAeasy Mini
Kit (Qiagen, Hilde, Germany).
Plasmids mutagenesis and Luciferase reporter assays
Luciferase reporter plasmids containing 3′-UTR of the EMP-1 gene
and empty luciferase vector were obtained from Active Motif
(Carlsbad, CA). The mutation was generated at the predicted target
site of miR-31 using the QuickChange XL site-directed mutagenesis
kit (Stratagene, Lo Jolla, CA) according to the manufacturer’s
instructions. The sequences of PCR primers for mutation are as
follows: forward 5′-gagaaagctaataaagaaaagtacggatgttgtctcagattctccct
ggggt-3′; reverse 5′-accccagggagaatctgagacaacatccgtacttttctttattagctt
tctc-3′. The mutation was veriﬁed by sequencing (Euroﬁns Geno-
mics, Ebersberg, Germany). Plasmids (200 ngml−1) were co-
transfected with pre-miR-31 or pre-miR-control (Ctr; 20 nM) into
human primary keratinocytes using Fugene HD transfection reagent
(Promega, Madison, WI). Forty-eight hours later, Luciferase activity
was analyzed using a LightSwitch Luciferase Assay Kit (Active Motif)
according to the manufacturer’s instructions.
Western blotting
EMP-1 protein expression was detected with mouse anti-human
EMP-1 antibody (1:1,000; Abcam, Cambridge, UK) and then
visualized using horseradish peroxidise (HRP)-conjugated anti-
mouse antibody (1:2,000; Dako Cytomation, Glostrup, Denmark).
As loading control, the blots were re-probed using HRP coupled anti-
human actin antibody (1:20,000) (Sigma-Aldrich, St Louis, MO).
Immunoﬂuorescence staining
Frozen human wound sections (5 μm) were rinsed with phosphate-
buffered saline, followed by incubation with 0.03% H2O2 for
10 minute. After blocking with 3% bovine serum albumin, the slides
were incubated with rabbit anti-human EMP-1 antibody (1:400,
Abcam) at 4 °C overnight. Matched IgG isotype controls were inclu-
ded for each staining. Primary antibodies were detected with Alexa
Fluor 594-conjugated goat anti-rabbit IgG (H+L; Life Technologies,
Carlsbad, CA) and visualized with a ﬂuorescence microscope.
Statistical analysis
All data are presented as mean± SD. Mann–Whitney U-test or
Student’s t-test was used to determine the signiﬁcance between two
groups. Correlation of the expression of different genes was made
using Pearson’s correlation test on log-transformed data. P-values
o0.05 were considered to be statistically signiﬁcant.
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